S
Siren
Developer of a diabetic foot monitoring system used to detect and treat diabetics
About Siren
Siren Care operates in the healthcare technology sector, specializing in remote patient monitoring solutions. The company’s core product is a smart sock that continuously monitors foot temperature, aimed at patients with neuropathy to prevent foot ulcers and other complications. Siren serves both patients and healthcare providers. Patients receive comfortable, temperature-monitoring socks shipped to their door every six months, along with access to web and mobile apps for real-time monitoring. Healthcare providers benefit from a remote monitoring platform that adheres to CMS guidelines, offering clinical population management tools and 24-hour support. Siren’s business model is subscription-based, generating revenue through the sale of its smart socks and associated monitoring services. The company targets a niche market of neuropathy patients and their healthcare providers, focusing on improving patient outcomes through early detection of foot injuries and inflammation.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- San Francisco, United States
- Employees
- 28
- Open positions
- None listed
- Dealroom signal
- 78.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Diabetes, Consumer Electronics, Remote Monitoring, Wearable, Insurtech Related, Hard Tech, remote health monitoring, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jan 2025 | $9.5M | $59M | Mölnlycke Health Care | ↗ |
| SERIES BEquity / VC | Aug 2021 | $9M | $36M | Mighty Capital · Manta Ray Ventures | ↗ |
Growth signals
Latest recorded traffic for Siren is 7.2K monthly website visits, down 19.1% over the last three months. Siren's team grew 12% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed11 investors entered at this stage
500 Global
Pascal Levy-Garboua- BBBragiel Brothers
Khosla Ventures
Plug and Play
Julie McDermott
A-Level Capital
DCM
Founders Fund
Leo Chan
Liquid 2 Ventures
Series A6 investors entered at this stage
James Conigliaro
Aloft VC (Formerly Anathem Ventures)
Mighty Capital
Portfolia Funds
David Helgason
Manta Ray Ventures
Series B and later1 investor entered at this stage
Mölnlycke Health Care
Other known investors12 additional known investors
- AVAnathem Ventures
Beni VC
BlueJay Syndicate- CUCSC Upshot
Flucas Ventures
Nucleate- PGPaul Grossinger
- PGPaul Grossinger
Sanabil Accelerator by 500 Global
SchindlerAM Ventures
SoGal Ventures
Western Technology Investment
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Siren on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Siren’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







